Clinical trial
Zoledronate or Observation in Maintaining Bone Mineral Density in Patients Who…
NCT00305695 · Gynecologic Oncology Group, Other · Completed
Key facts
| NCT number | NCT00305695 |
|---|---|
| Title | Zoledronate or Observation in Maintaining Bone Mineral Density in Patients Who Are Undergoing Surgery to Remove Both Ovaries |
| Official title | A Phase II Randomized Study of the Effect of Zoledronic Acid Versus Observation on Bone Mineral Density of the Lumbar Spine in Women Who Elect to Undergo Surgery That Results in Removal of Both Ovaries |
| Lead sponsor | Gynecologic Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hereditary Breast and Ovarian Cancer Syndrome, Osteoporosis, Ovarian Carcinoma |
| Intervention type | Drug, Other |
| Interventions | Laboratory Biomarker Analysis, Zoledronic Acid |
| Enrollment | 160 |
| Start date | Nov 28, 2005 |
| Primary completion | Dec 22, 2011 |
| First posted | Mar 22, 2006 |
| Last update posted | Mar 24, 2020 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: